Doctors say there are easy, inexpensive (or free!) arthritis self-care remedies that can make a world of difference. Odds are ...

Differences in how men and women manifest and experience psoriatic arthritis suggest it’s time to think of patient sex as a ...

Both trials recruited patients with psoriatic arthritis who had not previously received biologic disease-modifying ...

Long-term treatment with guselkumab is associated with sustained improvements in joint/skin symptoms and disease activity among patients with active PsA.

Stagnant sales for Bristol Myers Squibb’s Sotyktu have raised questions about whether the tyrosine kinase 2 (TYK2) inhibitor ...

(RTTNews) - Drug maker Bristol-Myers Squibb Co. (BMY) Monday announced positive topline results from two pivotal Phase 3 trials evaluating Sotyktu (deucravacitinib) in adults with active psoriatic ...

Bristol Myers on Monday said the two Phase 3 studies met their primary endpoint, with a significantly greater proportion of Sotyktu-treated patients achieving at least a 20% improvement in signs and ...

A research team from the University of Central Florida's College of Medicine conducted a study of patient perceptions of ...

From eczema and psoriasis to arthritis and Parkinson’s, the appearance of our hands can tell us a lot about the state of our ...

That’s why we’ve rounded up home products that reviewers with arthritis vouch for to make life easier and more comfortable — ...

Across 2024, top immunology news focused on ankylosing spondylitis, psoriatic arthritis, and rheumatoid arthritis, ...

Adult clinical trials found that Tremfya could treat plaque psoriasis by 16 weeks. Follow-up analysis found that roughly 23% of patients remained plaque free for more than 156 weeks. The Latest ...